In cattle, the metabolite neospiramycin, the demycarosyl derivative, is formed. Concentrations of neospiramycin in muscle and kidney were marginally higher than those of spiramycin 14-28 days after dosing; in muscle, levels of neospiramycin and spiramycin were approximately equal.
来源:Hazardous Substances Data Bank (HSDB)
代谢
spiramycin在肝脏中被代谢成活性代谢物；大量通过胆汁排出，约10%通过尿液排出。
Spiramycin is metabolized in the liver to active metabolites; substantial amounts are excreted in the bile and about 10% in the urine.
IDENTIFICATION AND USE: Spiramycin is a macrolide antibiotic used for the treatment and control of a number of bacterial and mycoplasmal infections in animals. It is available as a spiramycin embonate for use in animal feed, and as the adipate, a more soluble form, for administration by other routes. It has also been used in the protozoal infections cryptosporidiosis and toxoplasmosis. HUMAN EXPOSURE AND TOXICITY: Spiramycin is reported to cause contact dermatitis in occupational settings. A man who worked in a feed factory developed allergic contact dermatitis due to airborne spiramycin. The patient suffered recurrent outbreaks of eczematous lesions on uncovered areas during working periods. Spiramycin is also reported to cause hypersensitivity reactions. Rhinoconjunctivitis and spasmodic cough are reported in a 34 year-old female handling spiramycin powder in a pharmaceutical factory. The symptoms appeared within the first few hours of coming into contact with the drug and continued for several hours after leaving her place of work. One year after starting work in the pharmaceutical industry a 35-year-old non-atopic maintenance engineer developed attacks of sneezing, coughing and breathlessness. Inhalation challenge tests carried out in the hospital with gradually increasing quantities of spiramycin reproduced his symptoms and led to the development of late asthmatic reactions. Additionally, two cases of bronchial asthma due to spiramycin in workers of a pharmaceutical factory were reported. The subjects complained of cough, breathlessness and symptoms of asthma at work when coming into contact with spiramycin's powder. The symptoms cleared when away from work for more than 3 or 4 days. ANIMAL STUDIES: Groups of 2 male and 2 female monkeys (Macaca fascicularis) were given daily intravenous injections of 0, 240,000, 360,000, and 540,000 iu/kg bw/day spiramycin adipate for 5 days. Hypersalivation occurred during injection in all dose groups. Muscle hypotonia and nauseous spasticity occurred in several high dose monkeys and in one given the low dose. No abnormalities of body weights occurred but food consumption was reduced in all treated animals. A slight decrease in hemoglobin, red cell numbers and hematocrit was noted in high dose animals. In a short-term dietary study in which rats were given the equivalent of up to 3900 mg/kg bw for 13 weeks, the only major effects noted were a reduction in neutrophil counts in some mid- and high-dose animals, and the dilatation of the caecum. In another dietary study in the rat, animals were given up to the equivalent of 720 mg/kg bw/day for one year. The only notable effects were reductions in the body weights of females receiving the high doses, and increases in relative liver, kidney, and adrenal weights at high dose levels in animals of both sexes. Hepatic glycogen depletion occurred at all dose levels but not in controls. In mongrel dogs given 500 mg/kg bw/day for up to 56 days, reductions in spermatogenesis and testicular atrophy occurred. Kidney damage was also seen. When beagles were given orally spiramycin at up to the equivalent of 150 mg/kg bw/day for two years, testicular damage was not seen although degenerative changes occurred in other organs. In teratogenicity studies in mice, oral doses of spiramycin of up to 400 mg/kg bw given over days 5-15 of gestation had no effects on the outcome of pregnancy. intravenous doses of up to 84 mg/kg bw/day given on days 6-15 of gestation to rats and day 6-19 to rabbits had no effect on developmental, but oral dose of 200 and 400 mg/kg bw/day in rabbit produced caecal enlargement in mothers. Groups of 20 pregnant rats were treated intravenously on days 6-15 of gestation with doses of 0, 90 000, 180 000, and 270 000 iu/kg bw/day with spiramycin adipate. The highest dose given produced brief (5 minutes) ataxia and tremors immediately after dosing. A slight but significant reduction in fetal weight occurred at the intermediate dose but all values were within historical control ranges. There were no increased incidences of any fetal anomaly noted in this study. In a study where male rats were given doses of 30 mg/kg bw/day for 8 days by an unspecified route, mitotic and meiotic abnormalities in spermatogonia were noted. Negative result were obtained with spiramycin adipate and embonate in a forward-mutation test in mammalian cells in vitro, in an in vitro cytogenic assay, and in the mouse micronucleus test.
The macrolide antibiotics include natural members, prodrugs & semisynthetic derivatives. These drugs are indicated in a variety of infections & are often combined with other drug therapies, thus creating the potential for pharmacokinetic interactions. Macrolides can both inhibit drug metab in the liver by complex formation & inactivation of microsomal drug oxidising enzymes & also interfere with microorganisms of the enteric flora through their antibiotic effects. Over the past 20 yrs, a number of reports have incriminated macrolides as a potential source of clinically severe drug interactions. However, differences have been found between the various macrolides in this regard & not all macrolides are responsible for drug interactions. With the recent advent of many semisynthetic macrolide antibiotics it is now evident that they may be classified into 3 different groups in causing drug interactions. The first group (e.g. troleandomycin, erythromycins) are those prone to forming nitrosoalkanes & the consequent formation of inactive cytochrome P450-metabolite complexes. The second group (e.g. josamycin, flurithromycin, roxithromycin, clarithromycin, miocamycin & midecamycin) form complexes to a lesser extent & rarely produce drug interactions. The last group (e.g. spiramycin, rokitamycin, dirithromycin & azithromycin) do not inactivate cytochrome P450 & are unable to modify the pharmacokinetics of other cmpds. It appears that 2 structural factors are important for a macrolide antibiotic to lead to the induction of cytochrome P450 & the formation in vivo or in vitro of an inhibitory cytochrome P450-iron-nitrosoalkane metabolite complex: the presence in the macrolide molecules of a non-hindered readily accessible N-dimethylamino group & the hydrophobic character of the drug. Troleandomycin ranks first as a potent inhibitor of microsomal liver enzymes, causing a significant decr of the metab of methylprednisolone, theophylline, carbamazepine, phenazone (antipyrine) & triazolam. Troleandomycin can cause ergotism in patients receiving ergot alkaloids & cholestatic jaundice in those taking oral contraceptives. Erythromycin & its different prodrugs appear to be less potent inhibitors of drug metab. Case reports & controlled studies have, however, shown that erythromycins may interact with theophylline, carbamazepine, methylprednisolone, warfarin, cyclosporin, triazolam, midazolam, alfentanil, disopyramide & bromocriptine, decreasing drug clearance. The bioavailability of digoxin appears also to be increased by erythromycin in patients excreting high amounts of reduced digoxin metabolites, probably due to destruction of enteric flora responsible for the formation of these cmpds. These incriminated macrolide antibiotics should not be administered concomitantly with other drugs known to be affected metabolically by them, or at the very least, combined admin should be carried out only with careful patient monitoring.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
相互作用
已报告在给予螺旋霉素时，左旋多巴的血浆浓度降低。
Reduced plasma concentrations of levodopa have been reported when given with spiramycin.
The authors report the case of a 21 year old woman with a congenital long QT syndrome who had several syncopal attacks at least one of which was caused by torsades de pointes. This sudden complication was attributed to the simultaneous prescription of Spiramycine and Mequitazine over a 48 hour period. These two drugs are not considered to be predisposing factors for torsades de pointes despite the fact that they belong to two families of drugs which can trigger this type of arrhythmia. The withdrawal of this treatment led to the complete regression of the syncopal episodes with a follow-up of two years and a significant shortening of the initial QTc interval which remained, nevertheless, longer than normal. This case underlines the potential risks of drug associations of these two families of drugs, especially in patients with the congenital long QT syndrome.
/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/
Spiramycin is well absorbed in humans after oral administration. Oral administration of 15-30 mg/kg bw to healthy young male adults resulted in peak plasma levels in 3-4 hours and plasma concentrations of 0.96-1.65 mg/l. After intravenous dosing (7.25 mg/kg b.w.) a large volume of distribution (Vdss 5.6 l/kg) was observed indicating extensive tissue distribution. Biotransformation did not appear to be important. Biliary excretion was the main route of excretion; only 7-20% of an oral dose was excreted in the urine. Spiramycin is known to achieve high tissue:serum concentrations in pulmonary and prostatic tissues, and in skin.
Spiramycin crosses the placenta to the fetus. Concns of the antibiotic in maternal serum, cord blood, & the placenta after a dosage regimen of 2 g/day were 1.19 ug/ml, 0.63 ug/ml, & 2.75 ug/ml, respectively. When the maternal dose was increased to 3 g/day, the levels were 1.69 ug/ml, 0.78 ug/ml, & 6.2 ug/ml, respectively. Based on these results, the cord:maternal serum ratio is approx 0.5. Moreover, at these doses, spiramycin is concentrated in the placenta with levels approx 2-4 times those in the maternal serum. ... Spiramycin is excreted into breast milk. Nursing infants of mothers receiving 1.5 g/day for 3 days had spiramycin serum concns of 20 ug/ml. This concn was bacteriostatic.
/MILK/ Spiramycin is a macrolide antibiotic that is active against most of the microorganisms isolated from the milk of mastitic cows. This work investigated the disposition of spiramycin in plasma & milk after iv, intramuscular & subcutaneous admin. Twelve healthy cows were given a single injection of spiramycin at a dose of 30,000 IU/kg by each route. Plasma & milk were collected post injection. Spiramycin concn in the plasma was determined by a high performance liquid chromatography method, & in the milk by a microbiological method. The mean residence time after iv admin was significantly longer (P<0.01) in the milk (20.7 +/- 2.7 h) than in plasma (4.0 +/- 1.6 h). An average milk-to-plasma ratio of 36.5 +/- 15 was calculated from the area concn-time curves. Several pharmacokinetic parameters were examined to determine the bioequivalence of the two extravascular routes. The dose fraction adsorbed after intramuscular or subcutaneous admin was almost 100% & was bioequivalent for the extravascular routes, but the rates of absorption, the max concns & the time to obtain them differed significantly between the two routes. Spiramycin quantities excreted in milk did not differ between the two extravascular routes but the latter were not bioequivalent for max concn in the milk. However, the two routes were bio-equivalent for the duration of time the milk concn exceeded the minimal inhibitory concn (MIC) of various pathogens causing infections in the mammary gland.
Plasma protein binding ranges from 10 to 25%. An oral dose of 6 million units produces peak blood concentrations of 3.3 ug/mL after 1.5 to 3 hours; the half life is about 5 to 8 hours. High tissue concentrations are achieved and persist long after the plasma concentration has fallen to low levels.
![2-[(4R,5S,6S,7R,9R,10R,11E,13E,16S)-6-[(2S,3R,4R,5S,6R)-5-[(2R,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde化学式](data:image/svg+xml;base64,<?xml version="1.0" encoding="UTF-8"?>
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" width="300" height="300" viewBox="0 0 300 300">
<defs>
<g>
<g id="glyph-0-0">
<path d="M 0.421875 1.484375 L 0.421875 -5.953125 L 4.640625 -5.953125 L 4.640625 1.484375 Z M 0.890625 1.015625 L 4.171875 1.015625 L 4.171875 -5.46875 L 0.890625 -5.46875 Z M 0.890625 1.015625 "/>
</g>
<g id="glyph-0-1">
<path d="M 5.4375 -5.671875 L 5.4375 -4.796875 C 5.15625 -5.054688 4.851562 -5.25 4.53125 -5.375 C 4.21875 -5.507812 3.882812 -5.578125 3.53125 -5.578125 C 2.820312 -5.578125 2.28125 -5.359375 1.90625 -4.921875 C 1.53125 -4.492188 1.34375 -3.875 1.34375 -3.0625 C 1.34375 -2.257812 1.53125 -1.640625 1.90625 -1.203125 C 2.28125 -0.773438 2.820312 -0.5625 3.53125 -0.5625 C 3.882812 -0.5625 4.21875 -0.625 4.53125 -0.75 C 4.851562 -0.882812 5.15625 -1.082031 5.4375 -1.34375 L 5.4375 -0.46875 C 5.144531 -0.269531 4.832031 -0.117188 4.5 -0.015625 C 4.175781 0.078125 3.835938 0.125 3.484375 0.125 C 2.546875 0.125 1.804688 -0.160156 1.265625 -0.734375 C 0.734375 -1.304688 0.46875 -2.082031 0.46875 -3.0625 C 0.46875 -4.050781 0.734375 -4.832031 1.265625 -5.40625 C 1.804688 -5.976562 2.546875 -6.265625 3.484375 -6.265625 C 3.847656 -6.265625 4.191406 -6.210938 4.515625 -6.109375 C 4.835938 -6.015625 5.144531 -5.867188 5.4375 -5.671875 Z M 5.4375 -5.671875 "/>
</g>
<g id="glyph-0-2">
<path d="M 0.828125 -6.15625 L 1.65625 -6.15625 L 1.65625 -3.625 L 4.6875 -3.625 L 4.6875 -6.15625 L 5.515625 -6.15625 L 5.515625 0 L 4.6875 0 L 4.6875 -2.921875 L 1.65625 -2.921875 L 1.65625 0 L 0.828125 0 Z M 0.828125 -6.15625 "/>
</g>
<g id="glyph-0-3">
<path d="M 3.328125 -5.59375 C 2.722656 -5.59375 2.238281 -5.363281 1.875 -4.90625 C 1.519531 -4.457031 1.34375 -3.84375 1.34375 -3.0625 C 1.34375 -2.289062 1.519531 -1.679688 1.875 -1.234375 C 2.238281 -0.785156 2.722656 -0.5625 3.328125 -0.5625 C 3.929688 -0.5625 4.410156 -0.785156 4.765625 -1.234375 C 5.117188 -1.679688 5.296875 -2.289062 5.296875 -3.0625 C 5.296875 -3.84375 5.117188 -4.457031 4.765625 -4.90625 C 4.410156 -5.363281 3.929688 -5.59375 3.328125 -5.59375 Z M 3.328125 -6.265625 C 4.191406 -6.265625 4.878906 -5.972656 5.390625 -5.390625 C 5.910156 -4.816406 6.171875 -4.039062 6.171875 -3.0625 C 6.171875 -2.09375 5.910156 -1.316406 5.390625 -0.734375 C 4.878906 -0.160156 4.191406 0.125 3.328125 0.125 C 2.460938 0.125 1.769531 -0.160156 1.25 -0.734375 C 0.726562 -1.316406 0.46875 -2.09375 0.46875 -3.0625 C 0.46875 -4.039062 0.726562 -4.816406 1.25 -5.390625 C 1.769531 -5.972656 2.460938 -6.265625 3.328125 -6.265625 Z M 3.328125 -6.265625 "/>
</g>
<g id="glyph-0-4">
<path d="M 0.828125 -6.15625 L 1.953125 -6.15625 L 4.671875 -1 L 4.671875 -6.15625 L 5.484375 -6.15625 L 5.484375 0 L 4.359375 0 L 1.640625 -5.140625 L 1.640625 0 L 0.828125 0 Z M 0.828125 -6.15625 "/>
</g>
<g id="glyph-1-0">
<path d="M 0.28125 1 L 0.28125 -3.96875 L 3.09375 -3.96875 L 3.09375 1 Z M 0.59375 0.6875 L 2.78125 0.6875 L 2.78125 -3.65625 L 0.59375 -3.65625 Z M 0.59375 0.6875 "/>
</g>
<g id="glyph-1-1">
<path d="M 2.28125 -2.21875 C 2.550781 -2.15625 2.757812 -2.035156 2.90625 -1.859375 C 3.050781 -1.679688 3.125 -1.457031 3.125 -1.1875 C 3.125 -0.78125 2.984375 -0.46875 2.703125 -0.25 C 2.429688 -0.03125 2.039062 0.078125 1.53125 0.078125 C 1.351562 0.078125 1.171875 0.0625 0.984375 0.03125 C 0.804688 0 0.617188 -0.0507812 0.421875 -0.125 L 0.421875 -0.65625 C 0.578125 -0.570312 0.742188 -0.503906 0.921875 -0.453125 C 1.109375 -0.410156 1.304688 -0.390625 1.515625 -0.390625 C 1.859375 -0.390625 2.117188 -0.457031 2.296875 -0.59375 C 2.484375 -0.726562 2.578125 -0.925781 2.578125 -1.1875 C 2.578125 -1.425781 2.488281 -1.613281 2.3125 -1.75 C 2.144531 -1.894531 1.910156 -1.96875 1.609375 -1.96875 L 1.140625 -1.96875 L 1.140625 -2.421875 L 1.640625 -2.421875 C 1.910156 -2.421875 2.117188 -2.472656 2.265625 -2.578125 C 2.410156 -2.691406 2.484375 -2.847656 2.484375 -3.046875 C 2.484375 -3.265625 2.40625 -3.425781 2.25 -3.53125 C 2.101562 -3.644531 1.890625 -3.703125 1.609375 -3.703125 C 1.460938 -3.703125 1.300781 -3.6875 1.125 -3.65625 C 0.945312 -3.625 0.753906 -3.570312 0.546875 -3.5 L 0.546875 -4 C 0.765625 -4.0625 0.960938 -4.101562 1.140625 -4.125 C 1.328125 -4.15625 1.503906 -4.171875 1.671875 -4.171875 C 2.085938 -4.171875 2.414062 -4.070312 2.65625 -3.875 C 2.90625 -3.6875 3.03125 -3.429688 3.03125 -3.109375 C 3.03125 -2.878906 2.960938 -2.6875 2.828125 -2.53125 C 2.703125 -2.375 2.519531 -2.269531 2.28125 -2.21875 Z M 2.28125 -2.21875 "/>
</g>
</g>
</defs>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 237.941406 191.640625 L 254.246094 193.050781 L 254.246094 189.53125 L 237.941406 190.9375 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 9.333112 8.769719 L 9.136581 9.756997 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 9.139172 9.75089 L 8.577895 10.590862 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 8.588444 10.58383 L 7.59765 10.780915 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 8.488328 10.433934 L 7.59765 10.611033 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 7.603757 10.778509 L 6.760269 11.342007 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.778775 11.342007 L 5.935287 10.778509 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.778775 11.14159 L 6.055388 10.658222 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.941208 10.780915 L 4.950415 10.58383 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.960963 10.590862 L 4.399872 9.75089 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.402277 9.756997 L 4.205932 8.769719 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.205932 8.776196 L 4.402277 7.788919 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.399872 7.794841 L 4.959113 6.95783 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.954486 6.962456 L 5.791498 6.403215 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.785391 6.405806 L 6.772668 6.209276 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.766191 6.209276 L 7.753468 6.405806 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 7.747546 6.403215 L 8.584558 6.962456 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 8.628971 7.031297 L 9.11419 6.546079 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 8.51109 6.913416 L 8.996309 6.428198 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 8.579931 6.95783 L 8.955226 7.519847 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.792284 6.14284 L 6.74676 6.14284 M 6.798206 6.075665 L 6.740653 6.075665 M 6.804313 6.008489 L 6.734546 6.008489 M 6.81042 5.941314 L 6.728624 5.941314 M 6.816526 5.874138 L 6.722518 5.874138 M 6.822448 5.806963 L 6.716411 5.806963 M 6.828555 5.739972 L 6.710304 5.739972 M 6.834662 5.672796 L 6.704382 5.672796 M 6.840769 5.605621 L 6.698275 5.605621 M 6.846691 5.538445 L 6.692168 5.538445 M 6.852797 5.47127 L 6.686061 5.47127 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 163.464844 141.175781 L 159.230469 127.269531 L 155.976562 128.617188 L 162.8125 141.445312 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.606626 5.219778 L 5.820552 4.940897 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.926358 6.896761 L 4.893418 6.929886 M 4.883795 6.84476 L 4.841232 6.887138 M 4.841047 6.792759 L 4.789231 6.844575 M 4.798484 6.740573 L 4.73723 6.801827 M 4.755736 6.688572 L 4.685044 6.759264 M 4.713173 6.636571 L 4.633043 6.716701 M 4.67061 6.584385 L 4.581042 6.673953 M 4.627862 6.532385 L 4.528856 6.63139 M 4.585298 6.480384 L 4.476855 6.588827 M 4.542735 6.428198 L 4.424854 6.546079 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 135.785156 117.632812 L 130.601562 131.550781 L 134 132.460938 L 136.464844 117.8125 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.515717 5.294541 L 3.794922 4.573745 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.799363 4.589845 L 4.063069 3.605344 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.05141 3.617002 L 5.035911 3.353297 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.019811 3.34904 L 5.740422 4.069651 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.736166 4.053551 L 5.551109 4.743997 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 162.070312 92.210938 L 177.429688 89.550781 L 176.519531 86.152344 L 161.886719 91.53125 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.067186 3.294078 L 5.022217 3.28205 M 5.091799 3.228198 L 5.033876 3.212653 M 5.116411 3.162318 L 5.045534 3.143257 M 5.141024 3.096253 L 5.057193 3.073861 M 5.165451 3.030373 L 5.068851 3.004465 M 5.190064 2.964493 L 5.080695 2.935069 M 5.214676 2.898427 L 5.092354 2.865672 M 5.239289 2.832547 L 5.104012 2.796276 M 5.263901 2.766667 L 5.115671 2.72688 M 5.288329 2.700602 L 5.127329 2.657484 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.176045 2.127111 L 6.188074 2.172265 M 6.104984 2.13914 L 6.120528 2.197248 M 6.033922 2.151354 L 6.052983 2.22223 M 5.96286 2.163567 L 5.985252 2.247213 M 5.891798 2.175596 L 5.917706 2.272196 M 5.820922 2.18781 L 5.850161 2.297178 M 5.74986 2.199838 L 5.782615 2.322161 M 5.678798 2.212052 L 5.715069 2.347144 M 5.607736 2.224081 L 5.647339 2.372311 M 5.536675 2.236295 L 5.579793 2.397294 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.248773 2.140435 L 6.512663 1.155749 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.50082 1.167593 L 7.476068 0.906293 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 7.476068 0.906293 L 8.190017 1.620241 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 8.185575 1.604141 L 7.92187 2.588642 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 7.933713 2.576799 L 7.226982 2.766112 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 207.972656 60.800781 L 217.15625 71.976562 L 219.644531 69.488281 L 208.46875 60.304688 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 8.258488 1.61728 L 8.246459 1.572311 M 8.329549 1.605252 L 8.314005 1.547329 M 8.400611 1.593038 L 8.38155 1.522346 M 8.471488 1.581009 L 8.449096 1.497178 M 8.54255 1.568795 L 8.516642 1.472196 M 8.613611 1.556767 L 8.584372 1.447213 M 8.684673 1.544553 L 8.651918 1.42223 M 8.755735 1.532524 L 8.719464 1.397248 M 8.826797 1.520311 L 8.787009 1.372265 M 8.897673 1.508282 L 8.854555 1.347283 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 198.960938 25.527344 L 211.695312 18.328125 L 209.675781 15.445312 L 198.554688 24.949219 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 7.476068 0.906293 L 7.187935 0.288574 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 126.914062 82.15625 L 117.59375 70.851562 L 115.105469 73.339844 L 126.414062 82.65625 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.428324 2.628245 L 3.536027 2.226487 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.109657 2.97282 L 2.638873 3.099029 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.726451 4.576521 L 3.738479 4.621675 M 3.655389 4.588735 L 3.670934 4.646657 M 3.584327 4.600763 L 3.603388 4.67164 M 3.51345 4.612977 L 3.535842 4.696623 M 3.442389 4.625006 L 3.468297 4.721605 M 3.371327 4.63722 L 3.400566 4.746588 M 3.300265 4.649248 L 3.33302 4.771756 M 3.229203 4.661462 L 3.265475 4.796738 M 3.158142 4.673676 L 3.197929 4.821721 M 3.087265 4.685704 L 3.130383 4.846704 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.347501 7.746911 L 4.331401 7.785958 M 4.286987 7.716932 L 4.267556 7.764307 M 4.226659 7.687138 L 4.203712 7.742655 M 4.166145 7.657344 L 4.139682 7.721003 M 4.105632 7.627365 L 4.075838 7.699352 M 4.045118 7.597571 L 4.011993 7.6777 M 3.984605 7.567776 L 3.948148 7.656048 M 3.924091 7.537797 L 3.884119 7.634397 M 3.863578 7.508003 L 3.820274 7.612745 M 3.803249 7.478024 L 3.75643 7.591094 M 3.742736 7.44823 L 3.692585 7.569442 M 3.682222 7.418436 L 3.628556 7.54779 M 3.621709 7.388457 L 3.564711 7.526139 M 3.561195 7.358662 L 3.500867 7.504487 M 3.500682 7.328868 L 3.437022 7.482835 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.47903 7.418991 L 3.345974 6.408397 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.356152 6.421721 L 2.705863 6.152278 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.203481 6.538862 L 2.642204 6.30643 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.327144 9.759402 L 4.34491 9.80252 M 4.258859 9.780499 L 4.281806 9.835831 M 4.190573 9.80141 L 4.218701 9.869141 M 4.122287 9.822507 L 4.155597 9.902636 M 4.054186 9.843603 L 4.092493 9.935946 M 3.9859 9.864514 L 4.029203 9.969256 M 3.917614 9.885611 L 3.966099 10.002567 M 3.849513 9.906707 L 3.902995 10.036062 M 3.781227 9.927804 L 3.83989 10.069372 M 3.712941 9.948715 L 3.776786 10.102682 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.909333 10.639532 L 4.952451 10.657482 M 4.876948 10.700415 L 4.932465 10.723362 M 4.844563 10.761114 L 4.912479 10.789242 M 4.812178 10.821812 L 4.892307 10.855123 M 4.779793 10.882696 L 4.872321 10.920818 M 4.747408 10.943395 L 4.85215 10.986698 M 4.715023 11.004093 L 4.832164 11.052578 M 4.682638 11.064977 L 4.811993 11.118458 M 4.650253 11.125675 L 4.792007 11.184338 M 4.617868 11.186374 L 4.772021 11.250219 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.652613 11.653457 L 3.646691 11.608303 M 3.719974 11.650681 L 3.712386 11.593499 M 3.787149 11.647905 L 3.778081 11.578694 M 3.85451 11.645129 L 3.843777 11.564075 M 3.92187 11.642354 L 3.909657 11.54927 M 3.989231 11.639578 L 3.975352 11.534466 M 4.056592 11.636802 L 4.041047 11.519661 M 4.123767 11.634026 L 4.106742 11.504856 M 4.191128 11.631435 L 4.172622 11.490237 M 4.258488 11.628659 L 4.238317 11.475432 M 4.325849 11.625884 L 4.304012 11.460628 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.588954 11.647165 L 2.968459 10.838653 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.983818 10.844944 L 1.973409 10.978 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.986548 10.967822 L 1.596449 11.909575 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.594413 11.893105 L 2.214723 12.701618 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.199363 12.695326 L 2.942921 12.597431 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 87.253906 273.921875 L 80.503906 286.535156 L 83.753906 287.882812 L 87.902344 274.191406 "/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 74.683594 256.964844 L 58.53125 257.671875 L 58.988281 261.15625 L 74.773438 257.660156 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 0.419859 11.785032 L 0.194275 11.490977 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 0.493881 12.308557 L 0.348057 12.660535 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 9.192839 8.071686 L 9.333112 8.776196 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.206349 5.100786 L 4.499617 5.290099 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.724738 2.604557 L 6.244516 2.124335 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.320806 12.272656 L 3.586733 11.630695 " transform="matrix(21.108402, 0, 0, 21.108402, 40.949956, 6.107893)"/>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="256.09375" y="194.363281"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="261.40625" y="194.253906"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="267.199219" y="194.738281"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="233.699219" y="141.183594"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="230.5" y="173.660156"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="180.519531" y="119.15625"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="186.566406" y="119.046875"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="151.738281" y="124.878906"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="164.957031" y="108.132813"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="170.269531" y="108.023438"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="176.0625" y="108.507813"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="127.339844" y="141.183594"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="153.195312" y="115.328125"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="179.414063" y="89.476562"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="184.722656" y="89.367188"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="190.519531" y="89.855469"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="149.195312" y="59.625"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="184.507812" y="69.089844"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="220.191406" y="78.550781"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="225.503906" y="78.441406"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="231.296875" y="78.929688"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="230.75" y="37.773438"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="236.796875" y="37.664062"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="213.09375" y="16.203125"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="218.40625" y="16.09375"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="224.199219" y="16.578125"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="186.515625" y="9.179688"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="192.5625" y="9.070313"/>
</g>
<g fill="rgb(19%, 31%, 97.000003%)" fill-opacity="1">
<use xlink:href="#glyph-0-4" x="108.578125" y="70.558594"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="114.246094" y="50.164062"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="119.558594" y="50.054688"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="125.351562" y="50.539062"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="88.394531" y="76.015625"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="79.238281" y="75.90625"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="85.03125" y="76.390625"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="97.488281" y="111.332031"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="91.738281" y="111.222656"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="88.78125" y="136.574219"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="111.402344" y="223.144531"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="102.246094" y="223.035156"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="108.042969" y="223.519531"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="134.1875" y="252.117187"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="105.183594" y="274.375"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="76.542969" y="296.632812"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="81.855469" y="296.523438"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="87.648438" y="297.007812"/>
</g>
<g fill="rgb(19%, 31%, 97.000003%)" fill-opacity="1">
<use xlink:href="#glyph-0-4" x="50.640625" y="263.144531"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="37.996094" y="246.390625"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="28.839844" y="246.28125"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="34.632812" y="246.769531"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="42.765625" y="282.640625"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="48.078125" y="282.53125"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="53.871094" y="283.015625"/>
</g>
</svg>
)
